Endo Pharmaceuticals Aktie [WKN: 940110 / ISIN: US29264F2056]

Sende E-Mail

Analysen zur Endo Pharmaceuticals Holdings Inc.

02.05.2008Endo Pharmaceuticals Holdings DowngradeROTH Capital Partners, LLCneutal
02.05.2008Endo Pharmaceuticals Holdings neues KurszielLehman Brothers Inc.plus
27.03.2008Endo Pharmaceuticals Holdings positiveSusquehanna Financial Group, LLLPplus
06.03.2008Endo Pharmaceuticals Holdings buyROTH Capital Partners, LLCplus
26.02.2008Endo Pharmaceuticals outperformCowen and Company, LLCplus
26.02.2008Endo Pharmaceuticals Holdings overweightLehman Brothers Inc.plus
25.01.2008Endo Pharmaceuticals Holdings buyPacific Growth Equitiesplus
18.01.2008Endo Pharmaceuticals Holdings UpgradeCitigroup Corp.neutal
18.12.2007Endo Pharmaceuticals Holdings strong buyBuckingham Researchplus
08.10.2007Endo Pharmaceuticals Holdings neues KurszielUBS AGneutal
04.10.2007Endo Pharmaceuticals Holdings DowngradeJefferies & Company Inc.neutal
04.10.2007Endo Pharmaceuticals Holdings neues KurszielFriedman, Billings Ramsey & Coneutal
25.09.2007Endo Pharmaceuticals Holdings outperformCowen and Company, LLCplus
03.08.2007Endo Pharmaceuticals Holdings neues KurszielFriedman, Billings Ramsey & Coneutal
02.08.2007Endo Pharmaceuticals market performFriedman, Billings Ramsey & Coneutal
16.07.2007Endo Pharmaceuticals Holdings overweightLehman Brothersplus
12.07.2007Endo Pharmaceuticals buyRoth Capitalplus
12.07.2007Endo Pharmaceuticals sector performRBC Capital Marketsneutal
29.06.2007Endo Pharmaceuticals buyRoth Capitalplus
26.06.2007Endo Pharmaceuticals Holdings neues KurszielUBSplus
18.06.2007Endo Pharmaceuticals Holdings neues KurszielJefferies & Coplus
19.03.2007Endo Pharmaceuticals Holdings overweightLehman Brothersplus
19.03.2007Endo Pharmaceuticals Holdings outperformEvern Securitiesplus
26.02.2007Endo Pharmaceuticals Holdings neues KurszielJefferies & Coplus
26.02.2007Endo Pharmaceuticals Holdings outperformEvern Securitiesplus
23.02.2007Endo Pharmaceuticals Holdings neues KurszielLehman Brothersplus
02.02.2007Endo Pharmaceuticals Holdings strong buyFirst Albanyplus
01.02.2007Update Endo Pharmaceuticals Holdings Inc.: Strong First Albanyplus
10.01.2007Endo Pharmaceuticals overweightLehman Brothersplus
09.01.2007Endo Pharmaceuticals buyJefferies & Coplus
09.01.2007Update Endo Pharmaceuticals Holdings Inc.: OverweiLehman Brothersplus
09.01.2007Endo Pharmaceuticals outperformEvern Securitiesplus
13.12.2006Endo Pharmaceuticals holdWR Hambrecht+Coneutal
21.11.2006Update Endo Pharmaceuticals Holdings Inc.: NeutralSusquehanna Financialneutal
19.10.2006Endo Pharmaceuticals Holdings DowngradeCitigroupminus
19.10.2006Endo Pharmaceuticals Holdings DowngradeLeerink Swannneutal
05.10.2006Endo Pharmaceuticals Holdings neues KurszielEvern Securitiesplus
25.09.2006Endo Pharmaceuticals Holdings buyGoldman Sachsplus
08.09.2006Endo Pharmaceuticals Holdings positiveSusquehanna Financialplus
08.09.2006Endo Pharmaceuticals Holdings DowngradeCitigroupneutal
Seite: 1 | 2 weiter




Wie bewerten Sie diese Seite?   sehr gut        schlecht
 

Anzeige